BullScope
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal
No Result
View All Result
SUBSCRIBE
BullScope
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal
No Result
View All Result
BullScope
No Result
View All Result
Home Market News

Walmart’s operating income surges 28.8% as tariff refunds and eCommerce gains offset pricing pressure

Moe Alsumidaie, MBA, MSF by Moe Alsumidaie, MBA, MSF
August 24, 2026
in Market News
0
74
SHARES
1.2k
VIEWS
Share on XShare on LinkedInShare on Facebook

Walmart reported second-quarter revenue of $187.9 billion, up 5.9% from the prior year (5.1% in constant currency), with operating income jumping 28.8% to $2.1 billion. The acceleration masks a more complex picture: tariff refunds received in the quarter boosted gross profit by 158 basis points at Walmart U.S., while the company simultaneously invested those gains into customer pricing. Stripping out tariff impacts, adjusted operating income grew 17.4% in constant currency. The company raised its full-year fiscal 2027 guidance, now expecting net sales growth of 4.0% to 5.0% and adjusted operating income growth of 7.0% to 8.5%, both in constant currency.

Walmart U.S. comp sales grew 2.6% excluding fuel, a deceleration from 4.6% in the prior year quarter, though transactions rose 1.5% and eCommerce contributed approximately 510 basis points to the comp. Walmart U.S. net sales reached $125.2 billion, up 3.5%, with operating income up 20.6% to $8.1 billion. Sam’s Club U.S. comp sales grew 4.4% excluding fuel, down from 5.9% a year ago, though transactions surged 7.0%. Walmart International net sales grew 12.8% reported (7.9% in constant currency) to $35.2 billion, with operating income up 16.6% reported (5.7% in constant currency). Global eCommerce sales accelerated 23%, while the global advertising business grew 38%. For Q3, the company guides net sales growth of 3.0% to 3.75% and adjusted operating income growth of 2.0% to 4.0%, both in constant currency. Adjusted EPS came in at $0.81 for the quarter; the company guides $0.62 to $0.64 for Q3 and $2.80 to $2.87 for full-year FY27.

What it means

The headline operating income gain of 28.8% is largely a one-time event. The company received tariff refunds in Q2 and explicitly states it is reinvesting those refunds into customer pricing in the second half of the year, which will suppress operating income growth in coming quarters. Management notes that “setting aside this net impact, underlying operating income growth was at the top end of our guidance,” suggesting the operational performance underneath the tariff benefit was solid but not exceptional. The adjusted operating income growth of 17.4% in constant currency is the more durable measure and still represents acceleration from the prior year’s 4.7% full-year revenue growth and 4.2% operating margin.

The deceleration in Walmart U.S. comp sales from 4.6% to 2.6% year-over-year is the material operational question. The company attributes 80 basis points of headwind to health and wellness (pharmacy deflation from new maximum fair price regulation effective January 1), and notes that eCommerce contributed 510 basis points to the comp, implying the physical store comp would have been negative without digital. Transactions grew only 1.5% while average ticket fell 1.1%, suggesting customers are visiting more frequently but buying less per trip, a pattern consistent with price-conscious behavior. Sam’s Club U.S. also decelerated in comp sales (4.4% from 5.9%), though transactions accelerated sharply to 7.0%, again pointing to frequency gains offset by lower basket size. The company’s guidance for Q3 sales growth of 3.0% to 3.75% is materially lower than Q2’s 5.9%, and management explicitly warns of “over 100 bps headwind to growth related to a timing shift of Flipkart’s Big Billion Days between Q3 and Q4,” suggesting organic growth may be softer than the headline suggests.

BullScope TerminalYou just read Walmart Inc.’s filed numbers.Every claim above traces to a filing. Run any of 500+ companies through the same math-vs-mood engine. Free tier available.Open the Terminal →

The honest open question is whether the eCommerce contribution of 510 basis points at Walmart U.S. and 450 basis points at Sam’s Club masks a slowdown in physical store traffic and whether the company’s price investments will sustain transaction growth or merely arrest ticket decline. The inventory build of 6.7% (6.0% in constant currency) outpaced sales growth and is attributed to “strategic initiatives and inflation,” but the document does not specify which initiatives or quantify the inflation component, leaving unclear whether inventory is being deployed to support margin recovery or to hedge supply chain risk.

What to watch

The Q3 earnings release, expected in November 2026, will show whether the tariff reinvestment into pricing sustains the transaction growth seen in Q2 or whether average ticket continues to decline. The company’s own guidance for Q3 operating income growth of only 2.0% to 4.0% (versus 17.4% adjusted in Q2) signals management expects a material slowdown once tariff benefits are fully deployed to pricing. Watch also for the Flipkart Big Billion Days timing shift impact to clarify whether international eCommerce growth of 19% is structural or event-driven.

Source: the company’s 8-K filed 2026-08-20 with the SEC.

BullScope publishes impersonal research for a general audience. Nothing here is personalized investment advice, and nothing here is a recommendation to buy or sell any security. As of publication, neither BullScope nor its operator holds a position in any security, covered or otherwise; we do not trade at all, and we accept no compensation from any company we cover. When a conflict of interest exists, we do not publish: companies that compensate our operator in any capacity, or about which our operator could hold nonpublic information, are barred from coverage automatically, as described in the conflicts policy in our methodology. Figures come from company filings and public data through our published methodology; forecasts are conditional scenarios, not predictions and not promises. Markets carry risk, including loss of principal. Consider your own situation, or consult a licensed adviser, before acting on anything you read.

For the standing yardsticks on Walmart: the price tag, the filed record, and the four gauges, refreshed with each edition, see the BullScope Evidence Sheet: Walmart.

BullScope TerminalYou just read Walmart Inc.’s filed numbers.Every claim above traces to a filing. Run any of 500+ companies through the same math-vs-mood engine. Free tier available.Open the Terminal →
Moe Alsumidaie, MBA, MSF

Moe Alsumidaie, MBA, MSF

Moe Alsumidaie, MBA, MSF is the Chief Editor of BullScope. Trained in finance, with a Master of Science in Finance and an MBA, he spent years inside large public healthcare companies including Abbott, Genentech, and Roche, learning how the businesses behind the filings actually run. As a journalist and Chief Editor of The Clinical Trial Vanguard, his reporting has appeared in Applied Clinical Trials, The American Journal of Managed Care, and CNET, and has been cited in U.S. Supreme Court proceedings. At BullScope he brings those disciplines together: every note starts in the SEC filings, runs through published methodology, and shows its work.

Recommended For You

Adobe names Chakravarthy CEO as Narayen steps to executive chair

by Moe Alsumidaie, MBA, MSF
September 9, 2026
0

Adobe's board has named Anil Chakravarthy president and chief executive officer effective December 1, 2026, replacing Shantanu Narayen, who

Read moreDetails

AbbVie Reaffirms 2026 Guidance After Closing $10.9 Billion Apogee Acquisition

by Moe Alsumidaie, MBA, MSF
September 4, 2026
0

AbbVie completed its acquisition of Apogee Therapeutics for $10.9 billion in cash, adding two late-stage immunology assets to its pipeline

Read moreDetails

Moderna raises $2.6 billion in zero-coupon convertibles as revenue collapses, betting oncology turnaround

by Moe Alsumidaie, MBA, MSF
September 3, 2026
0

Moderna priced a $2.6 billion offering of convertible senior notes due 2032 on August 28, 2026, upsized from an initially planned $2.0 bill

Read moreDetails

Caterpillar renews three-year credit facility with unchanged $4 billion commitment as borrowing costs shift to SOFR

by Moe Alsumidaie, MBA, MSF
September 2, 2026
0

Caterpillar Inc. has executed a fifth amendment to its revolving credit agreement, dated August 27, 2026, maintaining a three-year facility

Read moreDetails

Boeing renews 364-day credit line as operating margin stays thin at 4.8%

by Moe Alsumidaie, MBA, MSF
September 1, 2026
0

Boeing has executed a new 364-day revolving credit agreement dated August 24, 2026, replacing its prior facility from August 25, 2025. The

Read moreDetails
Next Post

The Bill Nobody Voted For

Please login to join discussion
BullScope
The Research Terminal
Run any stock through the BullScope evidence engine. Filings in, evidence out. Every number explains itself.
Open the Terminal
A BullScope product

Related News

Netflix Is Earning More Than Ever. The Stock Is Down 37%. Both Things Are True.

August 21, 2026

The Golden Arches at a Discount: What $271 Assumes McDonald’s Will Never Do Again

August 24, 2026

Elanco Is Earning More Than It Ever Has. The Stock Is Priced Like That’s Just the Beginning.

August 27, 2026
BullScope

BullScope is an evidence-first investment research publication. Every note starts in the filings: what companies actually report, what the market assumes, and where the two disagree. We read the numbers so you can read the story. Not investment advice.

Prefer BullScope.ai on Google

© 2026 BullScope. Evidence-first investment research. Not investment advice.  ·  Methodology  ·  Privacy Policy  ·  Terms of Use  ·  Disclaimer

No Result
View All Result
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal

© 2026 BullScope. Evidence-first investment research. Not investment advice.  ·  Methodology  ·  Privacy Policy  ·  Terms of Use  ·  Disclaimer

Not enough quota to unlock this post
Unlock left : 0
Are you sure want to cancel subscription?
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.